Susanna Ekholm-Reed et al. develop a Parkinson mouse model by reducing Mcl-1 gene dosage by half, which leads to dopaminergic cell loss and motor impairments in Park2 knockout mice that otherwise do not exhibit any of the hallmark phenotypes associated with Parkinson’s disease. Here, PRKN is linked to Parkinson disease.